✦ LIBER ✦
A randomized, placebo-controlled, double-blind phase 2 study of docetaxel compared to docetaxel plus zosuquidar (LY335979) in women with metastatic or locally recurrent breast cancer who have received one prior chemotherapy regimen
✍ Scribed by Paul Ruff; D. A. Vorobiof; J. P. Jordaan; G. S. Demetriou; S. D. Moodley; A. L. Nosworthy; I. D. Werner; J. Raats; L. J. Burgess
- Publisher
- Springer
- Year
- 2009
- Tongue
- English
- Weight
- 225 KB
- Volume
- 64
- Category
- Article
- ISSN
- 0344-5704
No coin nor oath required. For personal study only.